Early Fluid Accumulation and Intensive Care Unit Mortality in Children Receiving Extracorporeal Membrane Oxygenation

Pilar Anton-Martin1, Raymond Quigley2, Archana Dhar3

  • 1From the Department of Pediatrics, Division of Cardiology - Cardiac Critical Care, University of Tennessee Medical Science Center / Le Bonheur Children's Hospital, Memphis, Tennessee.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|May 21, 2020
PubMed

Insights

Early fluid accumulation in children undergoing extracorporeal membrane oxygenation (ECMO) significantly increases intensive care unit (ICU) mortality. This finding highlights the importance of monitoring fluid balance in pediatric ECMO patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Nephrology

Background:

  • Extracorporeal membrane oxygenation (ECMO) is a life-support measure for critically ill neonates and children.
  • Fluid accumulation and acute kidney injury (AKI) are common complications during ECMO.
  • The impact of early fluid overload on mortality in pediatric ECMO patients requires further elucidation.

Purpose of the Study:

  • To evaluate the association between early fluid accumulation and renal dysfunction with mortality in pediatric patients receiving ECMO.
  • To identify risk factors for mortality in neonatal and pediatric ECMO patients.

Main Methods:

  • Retrospective cohort study of 96 neonatal and pediatric patients who received ECMO.
  • Data collected on fluid balance, acute kidney injury (AKI), continuous renal replacement therapy (CRRT), and mortality.
  • Multivariable logistic regression analysis adjusted for a propensity score.

Main Results:

  • Overall mortality was 38.5%.
  • Nonsurvivors had a higher proportion of AKI at ICU admission and greater fluid accumulation on ECMO day 1.
  • Fluid accumulation within 24 hours of ECMO initiation was significantly associated with increased ICU mortality (OR: 1.07, p = 0.04).

Conclusions:

  • Early fluid accumulation in the first 24 hours after ECMO cannulation is a significant predictor of increased ICU mortality in pediatric patients.
  • Conservative fluid management strategies and the role of CRRT during early ECMO warrant further investigation in prospective studies.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
902
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
655
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
690
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
365
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
327
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
124